Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Association between peripheral T-Lymphocyte activation and impaired bone mineral density in HIV-infected patients.

Gazzola L, Bellistri GM, Tincati C, Ierardi V, Savoldi A, Del Sole A, Tagliabue L, d'Arminio Monforte A, Marchetti G.

J Transl Med. 2013 Feb 28;11:51. doi: 10.1186/1479-5876-11-51.

2.

The CD4/CD8 ratio in HIV-infected subjects is independently associated with T-cell activation despite long-term viral suppression.

Serrano-Villar S, Gutiérrez C, Vallejo A, Hernández-Novoa B, Díaz L, Abad Fernández M, Madrid N, Dronda F, Zamora J, Muñoz-Fernández MÁ, Moreno S.

J Infect. 2013 Jan;66(1):57-66. doi: 10.1016/j.jinf.2012.09.013.

PMID:
23046968
3.

T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women.

Kaplan RC, Sinclair E, Landay AL, Lurain N, Sharrett AR, Gange SJ, Xue X, Hunt P, Karim R, Kern DM, Hodis HN, Deeks SG.

J Infect Dis. 2011 Feb 15;203(4):452-63. doi: 10.1093/infdis/jiq071.

4.

T-cell phenotypes, apoptosis and inflammation in HIV+ patients on virologically effective cART with early atherosclerosis.

Merlini E, Luzi K, Suardi E, Barassi A, Cerrone M, Martínez JS, Bai F, D'Eril GV, Monforte AD, Marchetti G.

PLoS One. 2012;7(9):e46073. doi: 10.1371/journal.pone.0046073.

5.

[T-lymphocyte immune in HIV-infected people and AIDS patients in China].

Li T, Qiu Z, Wang A, Sheng R.

Zhonghua Yi Xue Za Zhi. 2002 Oct 25;82(20):1391-5. Chinese.

PMID:
12509921
6.

T cell activation predicts carotid artery stiffness among HIV-infected women.

Kaplan RC, Sinclair E, Landay AL, Lurain N, Sharrett AR, Gange SJ, Xue X, Parrinello CM, Hunt P, Deeks SG, Hodis HN.

Atherosclerosis. 2011 Jul;217(1):207-13. doi: 10.1016/j.atherosclerosis.2011.03.011.

7.

Characterizing the immune system after long-term undetectable viral load in HIV-1-infected children.

Resino S, Galán I, Bellón JM, Navarro ML, León JA, Muñoz-Fernandez MA.

J Clin Immunol. 2003 Jul;23(4):279-89.

PMID:
12959220
8.

HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality.

Serrano-Villar S, Sainz T, Lee SA, Hunt PW, Sinclair E, Shacklett BL, Ferre AL, Hayes TL, Somsouk M, Hsue PY, Van Natta ML, Meinert CL, Lederman MM, Hatano H, Jain V, Huang Y, Hecht FM, Martin JN, McCune JM, Moreno S, Deeks SG.

PLoS Pathog. 2014 May 15;10(5):e1004078. doi: 10.1371/journal.ppat.1004078.

9.

[Characteristics of immunophenotypic alterations in 263 HIV/AIDS patients].

Xie J, Qiu ZF, Li TS, Han Y, Zuo LY, Ma XJ, Liu ZY, Wang AX.

Zhonghua Yi Xue Za Zhi. 2006 Apr 11;86(14):965-9. Chinese.

PMID:
16759536
10.

CD4(+) T-cell immunodeficiency is more dependent on immune activation than viral load in HIV-infected children on highly active antiretroviral therapy.

Resino S, Seoane E, Gutiérrez MD, León JA, Muñoz-Fernández MA.

J Acquir Immune Defic Syndr. 2006 Jul;42(3):269-76.

PMID:
16810122
11.

Immune reconstitution in HIV+ subjects on lopinavir/ritonavir-based HAART according to the severity of pre-therapy CD4+.

Marchetti G, Merlini E, Sinigaglia E, Iannotti N, Bai F, Savoldi A, Tincati C, Carpani G, Bini T, Arminio Monforte A.

Curr HIV Res. 2012 Oct;10(7):597-605.

PMID:
22716104
12.

Impact of suppression of viral replication by highly active antiretroviral therapy on immune function and phenotype in chronic HIV-1 infection.

Lange CG, Lederman MM, Madero JS, Medvik K, Asaad R, Pacheko C, Carranza C, Valdez H.

J Acquir Immune Defic Syndr. 2002 May 1;30(1):33-40.

PMID:
12048361
13.

Study of T cell subsets and IL-7 protein expression in HIV-1-infected patients after 7 years HAART.

Shou C, Weng N, Jin Y, Feng L, Jin C, Hoextermann S, Potthoff A, Skaletz-Rorowski A, Brockmeyer NH, Wu N.

Eur J Med Res. 2011 Nov 10;16(11):473-9.

14.

Immune activation, immunosenescence, and osteoprotegerin as markers of endothelial dysfunction in subclinical HIV-associated atherosclerosis.

D'Abramo A, Zingaropoli MA, Oliva A, D'Agostino C, Al Moghazi S, De Luca G, Iannetta M, Mastroianni CM, Vullo V.

Mediators Inflamm. 2014;2014:192594. doi: 10.1155/2014/192594.

15.

Abnormal Bone Acquisition With Early-Life HIV Infection: Role of Immune Activation and Senescent Osteogenic Precursors.

Manavalan JS, Arpadi S, Tharmarajah S, Shah J, Zhang CA, Foca M, Neu N, Bell DL, Nishiyama KK, Kousteni S, Yin MT.

J Bone Miner Res. 2016 Nov;31(11):1988-1996. doi: 10.1002/jbmr.2883.

PMID:
27283956
16.

Activation and coreceptor expression of T lymphocytes induced by highly active antiretroviral therapy in Chinese HIV/AIDS patients.

Zhang ZN, Shang H, Jiang YJ, Liu J, Dai D, Diao YY, Geng WQ, Jin X, Wang YN.

Chin Med J (Engl). 2006 Dec 5;119(23):1966-71.

PMID:
17199940
17.

Immunological changes after highly active antiretroviral therapy with lopinavir-ritonavir in heavily pretreated HIV-infected children.

Resino S, Galán I, Pérez A, Ramos JT, Bellón JM, Fontelos PM, de José MI, Gutiérrez MD, Cabrero E, Muñoz-Fernández MA.

AIDS Res Hum Retroviruses. 2005 May;21(5):398-406.

PMID:
15929702
18.

Increased cytolytic T lymphocyte activity and decreased B7 responsiveness are associated with CD28 down-regulation on CD8+ T cells from HIV-infected subjects.

Vingerhoets JH, Vanham GL, Kestens LL, Penne GG, Colebunders RL, Vandenbruaene MJ, Goeman J, Gigase PL, De Boer M, Ceuppens JL.

Clin Exp Immunol. 1995 Jun;100(3):425-33.

19.

Stimulated proliferative responses in vertically HIV-infected children on HAART correlate with clinical and immunological markers.

Resino S, Abad ML, Navarro J, Bellón JM, Sánchez-Ramón S, Angeles Muñoz-Fernández M.

Clin Exp Immunol. 2003 Jan;131(1):130-7.

20.

[Different immune profiles according to the immunological and clinical progression in vertically HIV-infected children].

Resino S, Abad ML, Bellón JM, Gurbindo D, León JA, Muñoz-Fernández MA.

Med Clin (Barc). 2002 Mar 2;118(7):241-6. Spanish.

PMID:
11882274
Items per page

Supplemental Content

Support Center